Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid

B. S. Tsai; L. K. Kessler; J. Stolzenbach; G. Schoenhard; R. F. Bauer

doi:10.1007/bf01297024

journal article May 01, 1991

Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid

B. S. Tsai L. K. Kessler J. Stolzenbach G. Schoenhard R. F. Bauer

Digestive Diseases and Sciences Vol. 36 No. 5 pp. 588-593 · Springer Science and Business Media LLC

View at Publisher Save 10.1007/bf01297024

Topics

No keywords indexed for this article. Browse by subject →

References

22

[1]

Robert A, Nezamis JE, Phillips JP: Effect of prostaglandin E1 on gastric secretion and ulcer formation in the rat. Gastroenterology 55:481?487, 1968 10.1016/s0016-5085(19)34024-7

[2]

Carmichael HA, Nelson LM, Russel RJ: Cimetidine and prostaglandin: Evidence for different modes of action on the rat gastric mucosa. Gastroenterology 74:1229?1232, 1978 10.1016/0016-5085(78)90697-2

[3]

Hakanson R, Leidberg G, Oscarson J: Effects of prostaglandin E1 on acid secretion, mucosal histamine content and histidine decarboxylase activity in rat stomach. Br J Pharmacol 47:487?503, 1973 10.1111/j.1476-5381.1973.tb08181.x

[4]

Roberts RP: Differentialin vivo pulmonary degradation of prostaglandin E1, B1, and A1. Am J Physiol 228:68?70, 1975 10.1152/ajplegacy.1975.228.1.68

[5]

Hammond GL, Cronau LH, Whitaker D, Gillis CN: Fate of prostaglandin E1 and A1 in the human pulmonary circulation. Surgery 81:716?722, 1977

[6]

Ferreira SH, Vane JR: Prostaglandins: Their disappearance from and release into the circulation. Nature 216:868?873, 1967 10.1038/216868a0

[7]

Anderson FL, Jubiz W, Tsagaris TJ: Degradation of prostaglandin E2 and F2? by the canine liver. Am J Physiol 231:426?429, 1976 10.1152/ajplegacy.1976.231.2.426

[8]

Collins PW: Development and therapeutic role of synthetic prostaglandins in peptic ulcer disease. J Med Chem 29:437?443, 1986 10.1021/jm00154a001

[9]

Rachmilewitz D, Chapman JW, Nicholson PA: A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients. Dig Dis Sci 31:75S-80S, 1986 10.1007/bf01309327

[10]

Lanza FL: A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects. Dig Dis Sci 31:131S-136S, 1986 10.1007/bf01309338

[11]

Dajani EZ, Driskill DR, Bianchi RG, Collins PW, Papper R: SC-29333: A potent inhibitor of canine gastric secretion. Dig Dis Sci 21:1049?1057, 1976 10.1007/bf01071862

[12]

Bundy G, Lincoln F, Nelson N, Pike J, Schneider W: Novel prostaglandin synthesis. Ann NY Acad Sci 180:76?90, 1971 10.1111/j.1749-6632.1971.tb53186.x

[13]

Strand JC, Miller MP, McGiff JC: Biological activity of the methyl esters of prostaglandin E2 and its (15S)-15-methyl analogue. Eur J Pharmacol 25:151?157, 1974 10.1016/0014-2999(74)90221-0

[14]

Schoenhard G, Oppermann J, Kohn FE: Metabolism and pharmacokinetic studies of misoprostol. Dig Dis Sci 30(suppl):126S-128S, 1985 10.1007/bf01309397

[15]

Tsai BS, Kessler LK, Collins PW, Kramer S, Bauer RF: Antisecretory activity of misoprostol, its racemates, stereoisomers and metabolites in isolated parietal cells. Prostaglandins 33(suppl):30?39, 1987 10.1016/0090-6980(87)90046-3

[16]

Krisch K: Reaction of a microsomal esterase from hog liver with diethyl para-nitrophenyl phosphate. Biochim Biophys Acta 122:265?280, 1966 10.1016/0926-6593(66)90067-1

[17]

Tsai BS, Kessler LK, Butchko GM, Bauer RF: Effect of misoprostol on histamine-stimulated acid secretion and cyclic AMP formation in isolated canine parietal cells. Dig Dis Sci 32:1010?1016, 1987 10.1007/bf01297192

[18]

Soll AH: Secretagogue stimulation of [14C]aminopyrine accumulation by isolated canine parietal cells. Am J Physiol 238:G366-G375, 1980

[19]

Tsai BS, Kessler LK, Schoenhard G, Collins PW, Bauer RF: Demonstration of specific E-type prostaglandin receptors using enriched preparations of canine parietal cells and [3H]misoprostol free acid. Am J Med 38(suppl 1A):9?14, 1987 10.1016/0002-9343(87)90572-9

[20]

Dajani EZ, Driskill DR, Bianchi RG, Collins PW: Comparative gastric antisecretory and antiulcer effects of prostaglandin E1 and its methyl ester in animals. Prostaglandins 10:205?216, 1975 10.1016/s0090-6980(75)80074-8

[21]

Magee WE, Armour SC, Miller OV: Absorption of prostaglandins by the intestine and vagina of the rat. Biochim Biophys Acta 306:270?282, 1973 10.1016/0005-2760(73)90232-4

[22]

Robert A, Magee WE, Miller OV, Nezamis JE: Intestinal absorption of prostaglandin F2?, 15(S)-15-methyl prostaglandin F2? and their methyl esters in the dog. Biochim Biophys Acta 348:269?278, 1974 10.1016/0005-2760(74)90238-0

Cited By

14

Prostanoid Receptors: Subtypes and Signaling

Richard M Breyer, Carey K Bagdassarian · 2001

Annual Review of Pharmacology and T...

Substitution of Charged Amino Acid Residues in Transmembrane Regions 6 and 7 Affect Ligand Binding and Signal Transduction of the Prostaglandin EP3 Receptor

Laurent Audoly, Richard M. Breyer · 1997

Molecular Pharmacology

Metrics

14

Citations

22

References

Details

Published: May 01, 1991
Vol/Issue: 36(5)
Pages: 588-593
License: View

Authors

Cite This Article

B. S. Tsai, L. K. Kessler, J. Stolzenbach, et al. (1991). Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid. Digestive Diseases and Sciences, 36(5), 588-593. https://doi.org/10.1007/bf01297024

Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid

You May Also Like